To view the full version of this video, please tell us more about yourself. »
Presenter(s):
Topic(s):
Bone Marrow Transplant
Aplastic Anemia
Myelodysplastic Syndromes (MDS)
Presentation Date:
Monday, September 14, 2020
Ryotaro Nakamura, MD is Professor, Department of Hematology & Hematopoietic Cell Transplantation; Director, Center for Stem Cell Transplantation at City of Hope.
Dr. Nakamura discusses the how the best practices for treating aplastic anemia and MDS have changed to include transplant as a realistic option for many patients over 40. With new conditioning regimes and improved matching, many patients can have a successful transplant well into their 70s. Dr. Nakamura also gives an overview of how aplastic anemia and MDS affect the bone marrow, a critical part of the decisionmaking process for determining if a transplant is an option.